Author

S. L. Lim

Primary ORCID profile (0009-0008-4979-1348 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

S. L. LimiD1 paper · National University of Singapore

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

B. C. Han· 1 shared L. Xu· 1 shared P. Koeffler· 1 shared P. Shyamsunder· 1 shared W. J. Chng· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B. C. Han

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Multiple Myeloma: Combination Therapy of BET Proteolysis Targeting Chimeric Molecule with CDK9 Inhibitor

S. L. Lim, P. Koeffler, L. Xu, B. C. Han, P. Shyamsunder, W. J. Chng

This study shows that combining a BET PROTAC (ARV 825) with a CDK9 inhibitor (AZD 4573) effectively reduces multiple myeloma cell viability and induces apoptosis.

bioRxiv · Apr 8, 2020Cancer Biology